Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomized trial. Lancet 2006; 367: 1555–1556., , , .
Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database of Systematic Reviews 2008; 3: CD001905., , .
Pervasive seizures caused by hypoxic-ischemic encephalopathy: treatment with intravenous paraldehyde. Journal of Child Neurology 2001; 16: 915–917., .
Paraldehyde toxicity during treatment of status epilepticus. American Journal of Diseases in Children 1982; 136: 414–415..
Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurology 2008; 7: 696–703., , , , , .
Paraldehyde therapy in childhood status epilepticus. Archives of Neurology 1983; 40: 477–480., , .
Compatibility of paraldehyde with plastic syringes and needle hubs. American Journal of Hospital Pharmacy 1984; 41: 306–308., .
Pharmacokinetics and parenteral use of phenytoin, phenobarbital, and paraldehyde. Epilepsia 1989; 30(Suppl 2): S1–S3..
Delivery of paraldehyde in 5% dextrose and 0.9% sodium chloride injections through polyvinyl chloride IV sets and burettes. American Journal of Hospital Pharmacy 1988; 45: 131–135., , .